A Comparative Study of the Outcome of High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation in Patients with High-Risk or Standard-Risk Myeloma Treated Concurrently

被引：0
|
作者：
Kazmi, Syed [1 ]
Lu, Gary [2 ]
Shah, Nina [3 ]
Bashir, Qaiser [3 ]
Parmar, Simrit
Orlowski, Robert Z. [4 ]
Shah, Jatin J. [2 ]
Hosing, Chitra M.
Popat, Uday [3 ]
Dinh, Yvonne T. [3 ]
Qureshi, Sofia [3 ]
Rondon, Gabriela [3 ]
Giralt, Sergio [3 ]
Champlin, Richard [3 ]
Qazilbash, Muzaffar H.
机构：
[1] Univ Texas MD Anderson Canc Hosp, Div Canc Med, Houston, TX USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1778 / 1778
页数：1
相关论文
共 50 条
  • [1] Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
    Kazmi, Syed M.
    Nusrat, Maliha
    Gunaydin, Hilal
    Cornelison, Amanda M.
    Shah, Nina
    Kebriaei, Partow
    Nieto, Yago
    Parmar, Simrit
    Popat, Uday R.
    Oran, Betul
    Shah, Jatin J.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (11): : 687 - 693
  • [2] Outcomes Among High Risk and Standard Risk Multiple Myeloma Patients Treated With High Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation
    Nusrat, Maliha
    Kazmi, Syed M.
    Cornelison, Amanda Megan
    Kebriaei, Partow
    Nieto, Yago
    Oran, Betul
    Orlowski, Robert Z.
    Parmar, Simrit
    Popat, Uday R.
    Shah, Jatin J.
    Shah, Nina
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    [J]. BLOOD, 2013, 122 (21)
  • [3] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF HIGH-RISK PEDIATRIC RHABDOMYOSACROMA PATIENTS
    Shiriaev, S. N.
    Makarova, I. V.
    Kazantsev, I. V.
    Gevorgyan, A. G.
    Kozlov, A. V.
    Youkhta, T. V.
    Klimov, A. S.
    Shvetsov, A. N.
    Morozova, E. V.
    Zubarovskaya, L. S.
    Afanasiev, B. V.
    Safonova, S. A.
    Punanov, Y. A.
    [J]. PEDIATRIC BLOOD & CANCER, 2013, 60 : 237 - 237
  • [4] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma
    Murakami, H
    Fujii, H
    Inaba, T
    Shimazaki, C
    Okamoto, S
    Miwa, A
    Sawamura, M
    Abe, M
    Chou, T
    Asaoku, H
    Kitahara, Y
    Hayashi, K
    Kosaka, M
    Togawa, A
    Takatsuki, K
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) : 169 - 173
  • [5] Genomic imbalances predict outcome in patients with high-risk breast cancer treated with high-dose chemotherapy and autologous stem cell transplantation
    Climent, J
    Martinez-Climent, JA
    Blesa, D
    Marugan, I
    Saez, R
    Sanchez, D
    Garcia, MJ
    Azagra, P
    Lluch, A
    Garcia-Conde, J
    [J]. BONE MARROW TRANSPLANTATION, 2002, 29 : S190 - S190
  • [6] The impact of extramedullary disease at presentation on the outcome of myeloma patients treated with high-dose therapy and autologous stem cell transplantation
    Pokrovskaya, O.
    Mandeleeva, L.
    Galayko, M.
    Urnova, E.
    Nareyko, M.
    Kovrigina, A.
    Kostina, I.
    Varlamova, E.
    Parovichnikova, E.
    Savchenko, V.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S206 - S206
  • [7] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [8] Impact of Maintenance Therapy in High-Risk Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation
    Bashir, Qaiser
    Milton, Denai
    Popat, Uday R.
    Oran, Betul
    Nieto, Yago
    Kebriaei, Partow
    Ciurea, Stefan O.
    Ahmed, Sairah
    Mehta, Rohtesh S.
    Olson, Amanda
    Parmar, Simrit
    Alatrash, Gheath
    Hosing, Chitra M.
    Shah, Nina
    Patel, Krina
    Weber, Donna
    Thomas, Sheeba
    Manasanch, Elisabet
    Lee, Hans C.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S243 - S244
  • [9] The Efficacy of High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Osteosarcoma
    Sakiyama, Hideki
    Hamada, Satoru
    Yagi, Takeshi
    Miyamoto, Jiro
    Oshiro, Tokiko
    Uehara, Taichi
    Kiyuna, Shinobu
    Tome, Yasunori
    Maehara, Hiroki
    Matsuda, Takehiro
    Higa, Takeshi
    Hyakuna, Nobuyuki
    Nakanishi, Koichi
    [J]. PEDIATRIC BLOOD & CANCER, 2019, 66 : S60 - S60
  • [10] Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: Risk factors analysis and outcome
    Gil, L.
    Styczynski, J.
    Komarnicki, M.
    [J]. INFECTION, 2007, 35 (06) : 421 - 427
12345